Mefpas D 80mg/250mg Tablet
Marketer
Martyn Nikk Pharma Private Limited
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Mefpas D 80mg/250mg Tablet
Combiflam D 80mg/250mg tablets offer relief from abdominal pain. This dual-action formulation eases abdominal pain, bloating, discomfort, and cramping by relaxing gastrointestinal muscles and inhibiting pain-inducing chemical signals. Always take Combiflam D 80mg/250mg tablets with food, following your doctor's prescribed dosage and duration. Treatment length depends on your individual response and condition; premature discontinuation may lead to symptom recurrence and worsening condition. Inform your physician of all other medications you're using, as interactions are possible. Common side effects include nausea, vomiting, diarrhea, stomach pain, dry mouth, appetite loss, thirst, and heartburn; most are transient. Report any concerning side effects immediately. Dizziness and drowsiness are potential side effects; avoid driving or activities requiring concentration until the drug's effects are known. Alcohol consumption should be avoided due to increased dizziness risk. If pregnant, planning pregnancy, breastfeeding, or have liver or kidney disease, consult your doctor before starting this medication to ensure appropriate dosage.
Primary Ingredients of Mefpas D 80mg/250mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Mefpas D 80mg/250mg Tablet
Managing discomfort in the abdomen
Major Benefits of Mefpas D 80mg/250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take the Mefpas D 80mg/250mg Tablet with a meal.
Common Side effects of Mefpas D 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Mefpas D 80mg/250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 80mg/250mg Mefpas D Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Mefpas D 80mg/250mg Tablet works:
Each Mefpas D 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle contractions. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory chemicals responsible for pain and swelling in the abdomen.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Mefpas D 80mg/250mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Mefpas D 80mg/250mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Mefpas D 80mg/250mg Tablet while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Mefpas D 80mg/250mg Tablets, a potential side effect of this medication, including dizziness.
KidneyCAUTION
Patients with impaired kidney function should use the 80mg/250mg Mefpas D tablet cautiously, potentially requiring a modified dosage. Consult a physician before use. The 80mg/250mg Mefpas D tablet is contraindicated for individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Mefpas D 80mg/250mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Mefpas D 80mg/250mg Tablet :
Should you forget a Mefpas D 80mg/250mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mefpas D 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently